Comparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Vaxil Bio Ltd. ?
Unrated Stock - No Analysis Available
Quality key factors
Factor
Value
Sales Growth (5y)
0.00%
EBIT Growth (5y)
0.00%
EBIT to Interest (avg)
-0.92
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.67
Sales to Capital Employed (avg)
0
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.62
EV to EBIT
-0.03
EV to EBITDA
-0.03
EV to Capital Employed
0.03
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-19.60%
ROE (Latest)
-17.80%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
Bullish
Bullish
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
No Trend
Bearish
OBV
Mildly Bullish
No Trend
Technical Movement
16What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CAD -0.21 MM
ROCE(HY)
Highest at -10.82%
RAW MATERIAL COST(Y)
Fallen by 0% (YoY
PRE-TAX PROFIT(Q)
At CAD -0.02 MM has Grown at 59.18%
NET PROFIT(Q)
At CAD -0.02 MM has Grown at 59.18%
-3What is not working for the Company
DEBT-EQUITY RATIO
(HY)
Highest at -88.61 %
CASH AND EQV(HY)
Lowest at CAD 1.2 MM
Here's what is working for Vaxil Bio Ltd.
Operating Cash Flow
Highest at CAD -0.21 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CAD MM)
Pre-Tax Profit
At CAD -0.02 MM has Grown at 59.18%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CAD MM)
Net Profit
At CAD -0.02 MM has Grown at 59.18%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (CAD MM)
Raw Material Cost
Fallen by 0% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Vaxil Bio Ltd.
Debt-Equity Ratio
Highest at -88.61 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Cash and Eqv
Lowest at CAD 1.2 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents






